ATAI LIFE SCIENCES N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.93 USD | +4.89% |
|
+4.32% | +36.88% |
Chart calendar Atai Life Sciences N.V.
655a6f59a.qNfgFKObqyOJygtxGyffHzLC9oy3OF5izIh8pf36PoY.mbmsIcnX-VPioDkTLBaqZl-knf76YQcqpsIv0besRvLG4M1zxK7bWcutYA~872c0903c5b1343420051e1a8dc48bf3
Upcoming events on Atai Life Sciences N.V.
Past events on Atai Life Sciences N.V.
| 04/04/2024 01:30 pm | Schizophrenia International Research Society Congress |
| 28/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 04/01/2024 06:30 pm | Business Update Call |
| 06/12/2023 03:30 am | American College of Neuropsychopharmacology Meeting |
| 14/11/2023 11:30 pm | Society for Neuroscience Meeting |
| 14/11/2023 05:33 pm | Q3 2023 Earnings Release |
| 11/10/2023 06:00 pm | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 28/09/2023 10:10 pm | Cantor Global Healthcare Conference |
| 20/09/2023 08:30 pm | TD Cowen Novel Mechanisms in Neuropsychiatry Summit |
| 12/09/2023 01:30 am | H.C. Wainwright Global Investment Conference |
| 07/09/2023 | Citi BioPharma Conference |
| 10/08/2023 04:29 pm | Q2 2023 Earnings Release |
| 26/06/2023 | H.C. Wainwright Neuropsychiatry Virtual Conference |
| 09/06/2023 06:30 pm | Jefferies Global Healthcare Conference |
| 16/05/2023 09:30 pm | Annual General Meeting |
| 11/05/2023 04:29 pm | Q1 2023 Earnings Release |
| 03/05/2023 09:00 pm | Aegis Virtual Conference |
| 28/04/2023 06:00 am | Society for Biological Psychiatry Meeting - Poster Number: T46 |
| 24/03/2023 04:29 pm | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,4 17,2 18.2% | 0,23 0,19 22.04% | 0,21 0,46 -53.04% | 0,25 |
|
EBITDA Million USD | Released Forecast Spread | -136 -120 -13.49% | -145 -146 0.66% | -125 -124 -0.64% | -120 |
|
EBIT Million USD | Released Forecast Spread | -136 -126 -7.83% | -145 -147 1.42% | -125 -124 -1.03% | -135 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -137 -126 -8.2% | -135 -136 0.65% | -39,3 -52,3 24.91% | -136 |
|
Net income Million USD | Released Forecast Spread | -168 -111 -50.83% | -152 -139 -9.27% | -40,2 -52,7 23.68% | -133 |
|
EPS USD | Released Forecast Spread | -1,21 -0,77 -56.97% | -0,98 -0,91 -7.78% | -0,25 -0,32 21.05% | -0,78 |
| Announcement Date | 30/03/22 | 24/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,23 0,01 1816.67% | 0,00 0,00 - | 0,17 0,00 - | 0,02 0,00 - | 0,04 0,11 -66.22% | 0,04 0,00 - | 0,17 0,00 3521.05% | 0,09 0,01 1544.61% | 0,02 0,13 -86.57% | 0,00 | 0,00 | 0,00 | 0,30 |
|
EBITDA Million USD | Released Forecast Spread | -45,1 -37,5 -20.39% | -33,4 -41,1 18.78% | -35,3 -48,4 26.99% | -38,4 -38,6 0.64% | -37,5 -40,1 6.38% | -33,1 -34,1 2.79% | -31,8 -33,9 6.11% | -26,8 -33,7 20.59% | -33,5 -29,7 -12.66% | -29,6 | -29,7 | -30,4 | -30,3 |
|
EBIT Million USD | Released Forecast Spread | -45,2 -38,0 -18.98% | -33,4 -41,0 18.37% | -35,4 -40,0 11.53% | -38,4 -38,9 1.1% | -37,6 -41,9 10.44% | -33,2 -37,1 10.56% | -31,9 -34,8 8.46% | -26,8 -33,0 18.74% | -33,6 -30,6 -9.79% | -30,8 | -33,1 | -33,1 | -34,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,6 -37,6 -29.09% | -31,9 -40,1 20.36% | -30,8 -39,4 21.89% | -33,1 -37,4 11.41% | -39,3 -40,0 1.69% | -33,2 -35,9 7.52% | -31,7 -35,0 9.62% | 43,8 -33,2 232.2% | -18,3 -30,8 40.47% | -30,7 | -33,2 | -33,4 | -35,2 |
|
Net income Million USD | Released Forecast Spread | -88,9 -37,1 -139.55% | -36,9 -38,5 4.36% | -36,6 -38,0 3.76% | -33,9 -37,3 9.21% | -45,0 -39,2 -14.83% | -33,1 -35,9 7.8% | -33,0 -34,4 3.94% | 44,2 -33,0 234.1% | -18,3 -29,5 38.05% | -30,0 | -32,4 | -32,6 | -34,3 |
|
EPS USD | Released Forecast Spread | -0,62 -0,23 -174.87% | -0,24 -0,24 -0.93% | -0,24 -0,23 -3.35% | -0,22 -0,23 5.58% | -0,28 -0,23 -22.81% | -0,21 -0,21 1.18% | -0,21 -0,21 -1.07% | 0,25 -0,20 224.11% | -0,12 -0,16 26.53% | -0,18 | -0,20 | -0,19 | -0,19 |
| Announcement Date | 30/03/22 | 16/05/22 | 15/08/22 | 10/11/22 | 24/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Atai Life Sciences N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATAI Stock
- Calendar Atai Life Sciences N.V.
